QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ast-spacemobile-and-polestar-automotive-are-among-top-10-best-performing-mid-cap-stocks-in-august-are-the-others-in-your-portfolio

The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, I...

 watching-shares-of-iovance-biotherapeutics-martin-shkreli-post-on-x-iova-pretty-attractive-long-idea

https://x.com/MartinShkreli/status/1826325256434315536

 hc-wainwright--co-reiterates-buy-on-iovance-biotherapeutics-maintains-32-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and maintains $...

 skin-cancer-focused-iovance-biotherapeutics-reports-better-than-expected-2024-2025-outlook-stock-surges

Iovance Biotherapeutics stock up 23.2% after issuing upbeat guidance for 2024 and 2025, beating Q2 earnings expectations.

Core News & Articles
Market-Moving News for August 9th
08/09/2024 12:16:31

KITT: 79% | Nauticus Robotics Partners With Florida Atlantic University For Cost-Effective Aquanaut Mark 2 Testing IOVA: 38% | ...

 iovance-biotherapeutics-q2-2024-adj-eps-034-beats-035-estimate-sales-3111m-beat-2459m-estimate

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate ...

 iovance-biotherapeutics-price-forecast-slashed-by-40-on-mutated-uptake-for-its-newly-approved-skin-cancer-cell-therapy

Piper Sandler downgraded Iovance Biotherapeutics due to a slow launch of Amtagvi (lifileucel), a skin cancer treatment. Despite...

 piper-sandler-downgrades-iovance-biotherapeutics-to-neutral-lowers-price-target-to-10

Piper Sandler analyst Joseph Catanzaro downgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Overweight to Neutral and lower...

 viasat--ast-spacemobile-are-among-top-6-mid-cap-stocks-that-shined-the-brightest-last-week-july-21-july-27-are-the-others-in-your-portfolio

Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION